<?xml version="1.0" encoding="UTF-8"?>
<p>6 to 8 weeks old BALB/c female mice were infected with 2 x 10
 <sup>5</sup> PFU MCMV
 <sup>WT</sup> and MCMV
 <sup>IVL</sup> diluted in PBS. For i.p. infection, 100 μl virus dilution was injected. For i.n. infection, mice were first anesthetized with ketamine (10 mg/ml) and xylazine (1 mg/ml) in 0.9% NaCl (100 μl/10 g body weight), then administered with 20 μl of virus suspension onto nostrils [
 <xref rid="ppat.1008036.ref035" ref-type="bibr">35</xref>]. For IAV challenge, BALB/c mice that were latently (&gt; 3 months) immunized with MCMV were i.n. inoculated with 220 focus forming units (FFU) or with 1100 FFU of PR8M influenza virus as described previously [
 <xref rid="ppat.1008036.ref035" ref-type="bibr">35</xref>].
</p>
